Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Wagner

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2023
Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant CarriersAnne-Sophie van der Werf-'t Lam, Diantha Terlouw, Carli M Tops, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Risks of less common cancers in proven mutation carriers with lynch syndromeChristoph Engel, Markus Loeffler, Verena Steinke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy RiskKasper A Overbeek, Brechtje D M Koopmann, Iris J M Levink, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2025
Cancer risks for MSH6 pathogenic variant carriersAnne-Sophie van der Werf-'t Lam, James G Dowty, Morrison Italia, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Gut|April 6, 2021
Long-term yield of pancreatic cancer surveillance in high-risk individualsKasper A Overbeek, Iris J M Levink, Brechtje D M Koopmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.
Familial Cancer|November 18, 2017
SNP association study in PMS2-associated Lynch syndromeSanne W Ten Broeke, Fadwa A Elsayed, Lisa Pagan, et al.
Human Mutation|February 27, 2010
Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patientsHeleen M van der Klift, Carli M J Tops, Elsa C Bik, et al.
Familial Cancer|March 9, 2021
Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center studyFloor A M Postema, Saskia M J Hopman, Corianne A J M de Borgie, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2023
Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant CarriersAnne-Sophie van der Werf-'t Lam, Diantha Terlouw, Carli M Tops, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Risks of less common cancers in proven mutation carriers with lynch syndromeChristoph Engel, Markus Loeffler, Verena Steinke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2023
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy RiskKasper A Overbeek, Brechtje D M Koopmann, Iris J M Levink, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2025
Cancer risks for MSH6 pathogenic variant carriersAnne-Sophie van der Werf-'t Lam, James G Dowty, Morrison Italia, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Gut|April 6, 2021
Long-term yield of pancreatic cancer surveillance in high-risk individualsKasper A Overbeek, Iris J M Levink, Brechtje D M Koopmann, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.
Familial Cancer|November 18, 2017
SNP association study in PMS2-associated Lynch syndromeSanne W Ten Broeke, Fadwa A Elsayed, Lisa Pagan, et al.
Human Mutation|February 27, 2010
Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patientsHeleen M van der Klift, Carli M J Tops, Elsa C Bik, et al.
Familial Cancer|March 9, 2021
Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center studyFloor A M Postema, Saskia M J Hopman, Corianne A J M de Borgie, et al.
Pageof 18